Reduced selenium-binding protein 1 in breast cancer correlates with poor survival and resistance to the anti-proliferative effects of selenium.
PLoS One. 2013 May 21;8(5):e63702. doi: 10.1371/journal.pone.0063702. Print 2013.
PLoS One. 2013.
PMID: 23704933
Free PMC article.